DUBLIN–(BUSINESS WIRE)–The “Fuchs Endothelial Corneal Dystrophy (FECD) (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Fuchs Endothelial Corneal Dystrophy (FECD) (Ophthalmology) – Drugs in Dev…
Author: Business Wire
Ocular Melanoma (Oncology) Pipeline Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Melanoma (Oncology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Ocular Melanoma (Oncology) – Drugs in Development, 2021 provides an overview of the Ocular Melanoma pipel…
Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today an un…
Global Optic Neuropathy (Ophthalmology) Drugs In Development 2021 Market Report – Featuring Antoxis, Astellas Pharma and Quark Pharmaceuticals – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuropathy (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Optic Neuropathy (Ophthalmology) pipeline landscape. Optic …
Allergic Rhino-Conjunctivitis (Ophthalmology) Drugs in Development, 2021 Research Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergic Rhino-Conjunctivitis (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Allergic Rhino-Conjunctivitis (Ophthalmology) – Drugs in Development, 2021 provides an…
Myopia (Ophthalmology) Drugs Development Research Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Myopia (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Myopia (Ophthalmology) – Drugs in Development, 2021 provides an overview of the Myopia pipeline landscape. Th…
2020 On-site Completes Observational Study that Confirms Eye Exams in Mobile Settings Have Same Results as In-Office Exams
BOSTON–(BUSINESS WIRE)–2020 On-site has completed its observational study to assess the quality of data in a mobile eye setting.
Endace Celebrates 20th Anniversary With Donation to The Glaucoma Foundation
AUCKLAND, New Zealand & NEW YORK–(BUSINESS WIRE)– #TGF_Glaucoma–To celebrate our 20th anniversary, Endace is donating to the 2021 TGF Art Challenge to benefit Glaucoma research and treatment.
Visus Therapeutics Expands Ophthalmic Drug Portfolio With Investigational Therapies for Glaucoma and Age-related Macular Degeneration; Secures Exclusive License for Novel Ophthalmic Drug Delivery Technology
SEATTLE–(BUSINESS WIRE)–Visus Therapeutics expands ophthalmic drug portfolio with investigational therapies for glaucoma and age-related macular degeneration.
Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland
WOODSTOCK, Ga.–(BUSINESS WIRE)–Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, includi…
NovaBay Pharmaceuticals to Distribute Zocular® Dry Eye Products
EMERYVILLE, Calif. & CYPRESS, Texas–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces an agreement with Okra Limited to distribute thei…
Oscar Wylee Announces Launch Into Canadian Market
EDMONTON, Alberta–(BUSINESS WIRE)– #Canada–Australian eyewear retailer, Oscar Wylee announces their expansion into Canada, with their first store set to open in West Edmonton Mall, Alberta at the end of August 2021. This comes on the back of the eye…
Boston Red Sox Legend David Ortiz to Star in new Zenni “PapiVision” Campaign
NOVATO, Calif.–(BUSINESS WIRE)– #BigPapi–Boston Red Sox legend David Ortiz is starring in Zenni’s latest “PapiVision” ad campaign launching exclusively on New England Sports Network.
DocSpace, Houston-Based Digital Health Startup, Raises $1.2 Million to Help Clinicians Build and Launch Independent Practices
HOUSTON–(BUSINESS WIRE)– #ClinicianEntrepreneurs–DocSpace, Houston-Based Digital Health Startup, Raises $1.2 Million to Help Clinicians Build and Launch Independent Practices
Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.
NASHVILLE, Tenn. & TOKYO–(BUSINESS WIRE)—- $HROW–Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced that it has entered into an agreement with Wakamoto Pharmaceutical Co., Ltd. to acquire the U.S. and Cana…
Alcon Reports Second Quarter 2021 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Second Quarter 2021 Results
VerkaziaTM (cyclosporine 0.1%) for the Treatment of Severe Vernal Keratoconjunctivitis is Now Reimbursed by Non-Insured Health Benefits (NIHB) Program
TORONTO–(BUSINESS WIRE)–VerkaziaTM (cyclosporine 0.1%) for the Treatment of Severe Vernal Keratoconjunctivitis is Now Reimbursed by Non-Insured Health Benefits (NIHB) Program
VerkaziaMC (cyclosporine à 0,1 %) est désormais remboursé par le Programme des services de santé non assurés (SSNA) pour traiter la kératoconjonctivite vernale grave
TORONTO–(BUSINESS WIRE)–Santen Canada Inc., filiale de Santen Pharmaceutical Co., Ltd. (« Santen »), société internationale œuvrant exclusivement dans le domaine de l’ophtalmologie, a annoncé aujourd’hui que VerkaziaMC (émulsion ophtalmique topique d…
Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results
WOODSTOCK, Ga.–(BUSINESS WIRE)–Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and, nasal …
Fabrinet Announces Fourth Quarter And Fiscal Year 2021 Financial Results
BANGKOK–(BUSINESS WIRE)– #Earnings–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today a…